Clinical Trial Update: A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study in healthy male volunteers comparing three concentrations of NN9535 has completed, providing initial pharmacokinetic and safety data. Sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NN9535

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED